Modulation of synaptic maintenance
C1q is shown to be expressed in neurons, where it acts as a signal for synapse elimination. Methods are provided for protecting or treating an individual suffering from adverse effects of synapse loss. These findings have broad implications for a variety of clinical conditions, including Alzheimer's disease.
1. A method of treating glaucoma, the method comprising
administering a therapeutic amount of a complement inhibitor to a patient suffering from glaucoma to thereby treat the glaucoma, wherein the complement inhibitor is an anti-C1q antibody.
2. The method according to claim 1 , further comprising administering one or more neural progenitors or a neurogenesis enhancer.
3. The method of claim 1 , wherein said complement inhibitor inhibits complement activation.